MariMed (OTC:MRMD) is gearing up to announce its quarterly earnings on Wednesday, 2026-03-11. Here's a quick overview of what investors should know before the release.

Analysts are estimating that MariMed will report an earnings per share (EPS) of $-0.01.

Anticipation surrounds MariMed's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

During the last quarter, the company reported an EPS beat by $0.01, leading to a 12.53% drop in the share price on the subsequent day.

Here's a look at MariMed's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.01	-0.01	-0.01	-0.010
EPS Actual	0.00	0.00	-0.01	-0.008
Price Change %	-12.53	-11.47	-3.24	-4.520

MariMed Share Price Analysis

Shares of MariMed were trading at $0.0821 as of March 09. Over the last 52-week period, shares are down 24.95%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for MariMed visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.